Fortrea Holdings Inc. (FTRE) Stock

NASDAQ: FTRECompany involved in various business activities, potentially including real estate and investments.

Fortrea stock price chart

FTRE interactive chart →

FTRE stock quote & key statistics

Fortrea earnings per share

Income →
Earnings per share

Fortrea revenue & net income

Income →
RevenueNet income

Fortrea annual financials

Income statement →
Fiscal yearRevenueNet incomeEPS
FY2025$2.72B-$986.2M$0.42
FY2024$2.70B-$328.5M$0.34
FY2023$2.84B-$25.2M$1.40
FY2022$2.84B$186.2M—
FY2021$3.06B$98.0M—

Fiscal year ending December 31. Source: company filings via EODHD.

About Fortrea Holdings Inc.

Fortrea Holdings Inc., a prominent contract research organization (CRO), specializes in providing comprehensive biopharmaceutical product and medical device development services on a global scale. The company operates through two key segments: Clinical Services and Enabling Services. Within the Clinical Services segment, Fortrea offers a broad spectrum of clinical pharmacology and clinical development services. These include phase I-IV clinical trial management, leveraging differentiated technology-enabled trial solutions, and providing post-approval services to its clientele.

In its Enabling Services segment, Fortrea Holdings delivers patient access and clinical trial technology solutions that optimize the complex processes of randomization and trial drug supply. These solutions are designed to enhance efficiency and streamline operations for pharmaceutical, biotechnology, and medical device companies worldwide. The company's service delivery models encompass full service, functional service provider (FSP), and hybrid structures, ensuring flexibility and tailored support to meet diverse client needs.

Founded in 2023 and headquartered in Durham, North Carolina, Fortrea Holdings Inc. continues to expand its capabilities and service offerings in the competitive CRO industry. With a focus on innovation and client satisfaction, Fortrea remains dedicated to advancing healthcare through its specialized expertise in clinical research and development.

Fortrea stock FAQ

What is the Fortrea stock ticker symbol?

Fortrea Holdings Inc. trades on the NASDAQ under the ticker symbol FTRE.

What sector and industry is Fortrea in?

Fortrea Holdings Inc. is classified in the Healthcare sector, Biotechnology industry.

How many employees does Fortrea have?

Fortrea Holdings Inc. has about 14,000 full-time employees.

What were Fortrea's revenue and earnings last fiscal year?

Fortrea reported revenue of $2.72B and net income of -$986.2M in fiscal 2025, with earnings per share of $0.42. Revenue grew 1.0% from the prior year.

Is Fortrea in the S&P SmallCap 600?

Yes. Fortrea Holdings Inc. (FTRE) is a component of the S&P SmallCap 600, the benchmark index of profitable U.S. small-cap stocks.

Is Fortrea in the Russell 2000?

Yes. Fortrea Holdings Inc. (FTRE) is a component of the Russell 2000, the benchmark index of U.S. small-cap stocks.

When did Fortrea go public?

Fortrea stock began trading on July 3, 2023.

S&P SmallCap 600 Biotechnology stocks

All S&P SmallCap 600 →